TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24827024

Group type: EXPERIMENTAL
Intervention: IPV-focused intervention
Number of subjects: 155

Group type: COMPARATOR
Intervention: Common factors intervention
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Community-based group interventions
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Children without symptoms of disinhibited social engagement disorder
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Children of parents with high levels of psychopathology
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Children of parents with high levels of parenting stress
Number of subjects: 155
Study: 22734377

Group type: EXPERIMENTAL
Intervention: Thread embedding at Changqiang (GV 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Indometacin suppository
Number of subjects: 80
Study: 20562752

Group type: EXPERIMENTAL
Intervention: 50 mg sertraline per day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study: 18984888

Group type: EXPERIMENTAL
Intervention: Daily supplementation of a combination of 2.5 mg of folic acid, 50 mg of vitamin B(6), and 1 mg of vitamin B(12) (n = 2721)
Number of subjects: 5442

Group type: COMPARATOR
Intervention: Placebo (n = 2721)
Number of subjects: 5442
Study: 15894946

Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg per day
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Irbesartan and Placebo
Number of subjects: 33
Study: 12126865

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 52
Study: 10424277

Group type: COMPARATOR
Intervention: alpha2b-interferon alone (6 months at 6 MU followed by 6 months at 3 MU three times weekly)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Combination of ribavirin and alpha2b-interferon (2 months ribavirin followed by 2 months of ribavirin with alpha2b-interferon at 1.0 or 1.2 g daily)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 64

Group type: COMPARATOR
Intervention: alpha2b-interferon alone
Number of subjects: 64
Study: 7574741

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy (group A) with high-dose intermittent 5-FU infusion at 1,000 mg/m2 for 5 hours a week.
Number of subjects: 27

Group type: COMPARATOR
Intervention: Usual hepatectomy (group B) without intra-arterial chemotherapy.
Number of subjects: 27
Study: 2153478

Group type: EXPERIMENTAL
Intervention: 1.25 mg intravenous enalaprilat
Number of subjects: 43
Study: 7308007

Group type: EXPERIMENTAL
Intervention: bezafibrate
Number of subjects: 120

Group type: COMPARATOR
Intervention: EPL
Number of subjects: 120

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 120
Study: 30817329

Group type: EXPERIMENTAL
Intervention: Lactoferrin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28112528

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (720 mg eicosapentaenoic acid plus 480 mg docosahexaenoic acid)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (edible paraffin)
Number of subjects: 45
Study: 26340282

Group type: EXPERIMENTAL
Intervention: Workplace initiative to reduce work-family conflict; costs of the intervention were $690 per participant.
Number of subjects: 0
Study: 22904118

Group type: EXPERIMENTAL
Intervention: 30‐15 Intermittent Ice Test (30‐15(IIT))
Number of subjects: 10
Study: 21272188

Group type: EXPERIMENTAL
Intervention: Low-dose insulin infusion (0.5 mU/kg/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Low-dose insulin infusion (1.5 mU/kg/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-dose insulin infusion (3.0 mU/kg/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-dose insulin infusion (5.0 mU/kg/min)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-dose insulin infusion (3.0 and 5.0 mU/kg/min)
Number of subjects: 8
Study: 19659602

Group type: EXPERIMENTAL
Intervention: Cobalt GVL Stat
Number of subjects: 32

Group type: COMPARATOR
Intervention: Miller laryngoscope
Number of subjects: 32
Study: 17157101

Group type: EXPERIMENTAL
Intervention: NuvaRing
Number of subjects: 983

Group type: COMPARATOR
Intervention: COC
Number of subjects: 983
Study: 12752054

Group type: EXPERIMENTAL
Intervention: Topical latanoprost 0.005%
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Topical brimonidine 0.2%
Number of subjects: 41
Study: 10943958

Group type: EXPERIMENTAL
Intervention: Rice-based hypo-osmolar ORS
Number of subjects: 58

Group type: COMPARATOR
Intervention: WHO-ORS
Number of subjects: 58

Group type: COMPARATOR
Intervention: Glucose-based hypo-osmolar ORS
Number of subjects: 58
Study: 9307711

Group type: EXPERIMENTAL
Intervention: Vitamin A (retinyl acetate 300,000 IU/week x 12 months)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Beta carotene (360 mg/week x 12 months)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 3547572

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular immunoglobulins against Pseudomonas aeruginosa
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: J5 antiserum to the core glycolipid of lipopolysaccharide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: J5 antiserum administered prophylactically to high-risk surgical patients
Number of subjects: 0
Study: 29239677

Group type: EXPERIMENTAL
Intervention: Kinect Adventures Training Group (KATG)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional Physical Therapy Group (CPTG)
Number of subjects: 46
Study: 27028133

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 94
Study: 25074851

Group type: EXPERIMENTAL
Intervention: Patient-to-patient model
Number of subjects: 89

Group type: COMPARATOR
Intervention: Nonparticipant group (control)
Number of subjects: 89
Study: 23483627

Group type: EXPERIMENTAL
Intervention: istradefylline 20 mg/day
Number of subjects: 373

Group type: EXPERIMENTAL
Intervention: istradefylline 40 mg/day
Number of subjects: 373

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 373
Study: 20452283

Group type: EXPERIMENTAL
Intervention: Overnight-fasted (FAST)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Acutely fed (FED)
Number of subjects: 14
Study: 18775668

Group type: EXPERIMENTAL
Intervention: LTA-T (750-1500 microg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 14
Study: 15505268

Group type: EXPERIMENTAL
Intervention: 12 issues of an evidence‐based series called Therapeutics Letter (intervention group, n = 258)
Number of subjects: 499

Group type: COMPARATOR
Intervention: Control group (n = 241)
Number of subjects: 499
Study: 11462946

Group type: EXPERIMENTAL
Intervention: 5-day course of leucovorin (200 mg/m2/day), 5-fluorouracil (375 mg/m2/day), and cisplatin (15 mg/m2/day) repeated every 21 days
Number of subjects: 45

Group type: COMPARATOR
Intervention: Supported care alone (control group)
Number of subjects: 45
Study: 9781723

Group type: EXPERIMENTAL
Intervention: Enalaprilat (0.25 mg/hr)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (saline solution)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 8143426

Group type: EXPERIMENTAL
Intervention: 100 g of glucose in 300 ml of water (n = 8)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 50 g of fat in 250 ml of water (n = 8)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 100 g of lean meat corresponding to 40 g of protein with 250 ml of water (n = 8)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Mixed meal (1750 kJ) (n = 8)
Number of subjects: 39

Group type: COMPARATOR
Intervention: 300 ml of water only (n = 7)
Number of subjects: 39
Study: 3262175

Group type: EXPERIMENTAL
Intervention: Postoperative infusion of a 3% amino acid solution
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no amino acid infusion)
Number of subjects: 18
Study: 31871950

Group type: EXPERIMENTAL
Intervention: Theracurmin® (180 mg daily for 6 months)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Theracurmin®
Number of subjects: 33
Study: 28483174

Group type: EXPERIMENTAL
Intervention: Multimodal Intervention (MI) including care from psychiatry, general medicine, neuropsychology, family therapy, and occupational therapy
Number of subjects: 302

Group type: COMPARATOR
Intervention: Traditional Intervention (TI) including care from psychiatry and general medicine
Number of subjects: 302
Study: 26573034

Group type: EXPERIMENTAL
Intervention: Balance training exercises for 2 weeks
Number of subjects: 24
Study: 23656980

Group type: EXPERIMENTAL
Intervention: Basal insulin glargine
Number of subjects: 12537

Group type: COMPARATOR
Intervention: Standard glycemic care
Number of subjects: 12537
Study: 20456557

Group type: EXPERIMENTAL
Intervention: Two-compound scalp formulation (calcipotriol 50 μg/g and betamethasone 0.5 mg/g)
Number of subjects: 2920

Group type: COMPARATOR
Intervention: Betamethasone dipropionate
Number of subjects: 2920

Group type: COMPARATOR
Intervention: Calcipotriol
Number of subjects: 2920

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 2920
Study: 18617654

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily
Number of subjects: 4729
Study: 17091007

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral anger management program (120 minutes per session, three consecutive sessions, once a week)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 26
Study: 12932301

Group type: EXPERIMENTAL
Intervention: Advice and individualized sub‐maximal exercise programs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 10874228

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 120

Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Active treatment group (Sotalol and Amiodarone combined)
Number of subjects: 120
Study: 9107560

Group type: EXPERIMENTAL
Intervention: Bisoprolol (titrated up to 10 mg, starting with 1.25 mg daily)
Number of subjects: 2500
Study: 1601837

Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT)
Number of subjects: 31
Study: 3516704

Group type: EXPERIMENTAL
Intervention: Nifedipine (5 mg tds to 15 mg tds)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 23
Study: 31573615

Group type: EXPERIMENTAL
Intervention: FR 85% 5-14
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: FR 85% 1-14
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control
Number of subjects: 300
Study: 28993707

Group type: EXPERIMENTAL
Intervention: Active commuting (BIKE, n=35)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise (MOD, n=39)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise (VIG, n=38)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Vigorous intensity exercise (VIG)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (CON, n=18)
Number of subjects: 130
Study: 28065235

Group type: EXPERIMENTAL
Intervention: telmisartan + analog traditional Chinese medicine (TA)
Number of subjects: 270

Group type: COMPARATOR
Intervention: traditional Chinese medicine + analog telmisartan (TCMA)
Number of subjects: 270

Group type: COMPARATOR
Intervention: telmisartan + traditional Chinese medicine (TTCM)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: liver function and abnormal serum potassium rate
Number of subjects: 270
Study: 25376415

Group type: EXPERIMENTAL
Intervention: Multicomponent lifestyle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 22142894

Group type: EXPERIMENTAL
Intervention: Experimental conditions (4 groups)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Control group (1 group)
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Overall sample
Number of subjects: 243
Study: 19823111

Group type: EXPERIMENTAL
Intervention: SPL7013 Gel 0.5% (N = 8)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: SPL7013 Gel 1% (N = 8)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: SPL7013 Gel 3% (N = 9)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo gel (N = 12)
Number of subjects: 37
Study: 17094973

Group type: EXPERIMENTAL
Intervention: Edwards‐Wallace embryo-transfer catheter
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cook World embryo-transfer catheter
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flare stimulation protocol
Number of subjects: 100
Study: 15293054

Group type: EXPERIMENTAL
Intervention: Eccentric exercise (ECC) - 50 maximal voluntary eccentric contractions at 30 degrees x s(‐1)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Isometric exercise (ISO) - 50 maximal voluntary isometric contractions at a lengthened position
Number of subjects: 14

Group type: COMPARATOR
Intervention: Eccentric exercise (ECC)
Number of subjects: 14
Study: 11672461

Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ) at 10 mg/kg per day for 3 days
Number of subjects: 210

Group type: COMPARATOR
Intervention: Chloroquine (CQ) at 10 mg/kg per day for 3 days
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Chloroquine (CQ)
Number of subjects: 210
Study: 9828551

Group type: EXPERIMENTAL
Intervention: Pyridoxine hydrochloride 100 mg daily one hour before radiation therapy for 7 days
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (irradiation alone)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Pyridoxine hydrochloride
Number of subjects: 104
Study: 7735088

Group type: EXPERIMENTAL
Intervention: Case management program
Number of subjects: 0
Study: 2743965

Group type: EXPERIMENTAL
Intervention: 1200 kcal lactovegetarian diet
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Isocaloric mixed diet
Number of subjects: 110

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 110
Study: 30848025

Group type: EXPERIMENTAL
Intervention: Propofol/remifentanil (PR group)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Propofol (P group)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99
Study: 28029066

Group type: EXPERIMENTAL
Intervention: High load without BFR (HL) (70% VO2max)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low load with BFR (LL‐BFR) (40% VO2max + 50% BFR)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low load without BFR (LL) (40% VO2max)
Number of subjects: 21
Study: 26302024

Group type: EXPERIMENTAL
Intervention: Probiotics (cultured Lactobacillus subtilis/Streptococcus faecium) 1500 mg/day for 7 days
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study: 24250224

Group type: EXPERIMENTAL
Intervention: Scaling and root planing
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling and root planing
Number of subjects: 33

Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 33
Study: 22007715

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Control (non-malaria comparator vaccine)
Number of subjects: 6000
Study: 17534670

Group type: EXPERIMENTAL
Intervention: DVD plus usual care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 17288757

Group type: EXPERIMENTAL
Intervention: Tirofiban (10 microg/kg bolus i.v. followed by 0.15 microg x kg(‐1) x min(‐1) for 36 hours) administered early before PCI
Number of subjects: 158

Group type: COMPARATOR
Intervention: Tirofiban administered late before PCI
Number of subjects: 158
Study: 14723152

Group type: EXPERIMENTAL
Intervention: Amifostine (amifostinum) used during polychemotherapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Polychemotherapy alone (Control group)
Number of subjects: 10
Study: 15728061

Group type: EXPERIMENTAL
Intervention: Esmolol (bolus of 1 mg/kg and then 0.25 mg x kg(‐1) x min(‐1))
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Landiolol (bolus of 0.125 mg/kg and then 0.04 mg x kg(‐1) x min(‐1))
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (saline infusion)
Number of subjects: 45
Study: 10473886

Group type: EXPERIMENTAL
Intervention: Patients with acute leukemia
Number of subjects: 18

Group type: COMPARATOR
Intervention: Patients with iron deficiency anemia (control group)
Number of subjects: 18
Study: 8566840

Group type: EXPERIMENTAL
Intervention: 2 mg terlipressin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 50 micrograms octreotide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 30
Study: 2008946

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine sulfate (ITMS) 15 micrograms/kg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (CTRL) group (no actual dural puncture)
Number of subjects: 22
Study: 7042252

Group type: EXPERIMENTAL
Intervention: Cimetidine (1 g daily)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Propantheline (optimally effective dose)
Number of subjects: 71
Study: 27154526

Group type: EXPERIMENTAL
Intervention: Acute coronary angiography (CAG)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Subacute coronary angiography (CAG)
Number of subjects: 250
Study: 26066615

Group type: EXPERIMENTAL
Intervention: Acellular dermal matrix (ADM) implantation
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (without ADM)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 44
Study: 24945085

Group type: EXPERIMENTAL
Intervention: Guanfacine extended release (GXR) adjunctive to psychostimulant (1-4 mg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo adjunctive to psychostimulant
Number of subjects: 0
Study: 22972364

Group type: EXPERIMENTAL
Intervention: Intensive statin therapy (pitavastatin or atorvastatin)
Number of subjects: 242
Study: 19167094

Group type: EXPERIMENTAL
Intervention: Unsupported online computerized cognitive behavioral therapy (CCBT)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Expectancy of CCBT
Number of subjects: 200
Study: 17276261

Group type: EXPERIMENTAL
Intervention: Tecnis Z9000 silicone IOL
Number of subjects: 43

Group type: COMPARATOR
Intervention: AcrySof IQ SN60WF acrylic IOL
Number of subjects: 43
Study: 15213077

Group type: EXPERIMENTAL
Intervention: 50 mg.kg(‐1) of tranexamic acid at induction of anesthesia (Group B)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 10 mg.kg(‐1) at induction followed by an infusion of 1 mg.kg(‐1).h(‐1) (Group C)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 10 mg.kg(‐1) at induction, 10 mg.kg(‐1) on bypass, and 10 mg.kg(‐1) after protamine (Group D)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: 20 mg.kg(‐1) at induction and again after protamine (Group E)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (Group A)
Number of subjects: 150
Study: 11210578

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin + Tobramycin (CIP + T)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Ciprofloxacin + Placebo (CIP + P)
Number of subjects: 118
Study: 9879617

Group type: EXPERIMENTAL
Intervention: Magnesium infusions in acute myocardial infarction
Number of subjects: 0
Study: 7982129

Group type: COMPARATOR
Intervention: Placebo (3.5 ml saline)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.1 mg ANP (dissolved in 3.5 ml saline)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1 mg ANP (dissolved in 3.5 ml saline)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 0.1 mg ANP
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1 mg ANP
Number of subjects: 8
Study: 2660373

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (Mucomyst) administered systemically in the recommended dosage
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 110
Study: 31232957

Group type: EXPERIMENTAL
Intervention: Comfort care
Number of subjects: 100
Study: 28252160

Group type: EXPERIMENTAL
Intervention: Audiology best practices (AB)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Consumer decides OTC model (CD)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo devices (P)
Number of subjects: 154
Study: 26490826

Group type: EXPERIMENTAL
Intervention: Simulation-based teaching
Number of subjects: 39

Group type: COMPARATOR
Intervention: Lecture-based teaching
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 39
Study: 24168460

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Jing-jiaji points for 30 minutes, five sessions per week for a total of 20 sessions over four weeks.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acupuncture at Jing-jiaji points for 30 minutes, five sessions per week for a total of 20 sessions over four weeks.
Number of subjects: 0
Study: 21320549

Group type: EXPERIMENTAL
Intervention: One dose of PCV7
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Two doses of PCV7
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Three doses of PCV7
Number of subjects: 684

Group type: EXPERIMENTAL
Intervention: Booster with PPV
Number of subjects: 684
Study: 21344811

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (10 sessions, twice a week)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Night splinting (prefabricated volar neutral wrist splint during the night for 5 weeks)
Number of subjects: 61
Study: 17634060

Group type: EXPERIMENTAL
Intervention: Ganaxolone (1 mg/kg, b.i.d. to 12 mg/kg t.i.d. over 16 days, followed by 8 weeks maintenance)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ganaxolone
Number of subjects: 15
Study: 16155694

Group type: EXPERIMENTAL
Intervention: High pull J hook headgear (HPHG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-HPHG
Number of subjects: 60
Study: 12095015

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at 0.5 microg kg(‐1) min(‐1)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Fentanyl bolus dose of 1.5 microg kg(‐1)
Number of subjects: 72
Study: 10022407

Group type: COMPARATOR
Intervention: Radioiodine
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Radioiodine plus lithium
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 110